Gut and bladder fermentation syndromes: a narrative review.

Area of Science:

• Medical Mycology
• Endocrinology
• Toxicology

Background:

• Bladder fermentation syndrome (BFS), or urinary auto-brewery syndrome, is a rare condition where yeast generates ethanol within the bladder.
• BFS is linked to poorly controlled diabetes and fermentation by Candida glabrata, a Crabtree-positive yeast.
• Unlike gut fermentation syndrome (GFS), BFS is characterized by the absence of alcoholic intoxication due to low ethanol permeability of the bladder epithelium.

Purpose of the Study:

• To differentiate BFS from GFS based on clinical and laboratory findings.
• To highlight the diagnostic challenges and potential legal ramifications of under-recognized fermentation syndromes.
• To emphasize the importance of accurate diagnosis for appropriate treatment and patient management.

Main Methods:

• Case report analysis of BFS and comparison with GFS.
• Review of diagnostic criteria including urinalysis (glucose, ethanol, metabolites, yeast presence) and carbohydrate challenge tests.
• Discussion of treatment strategies involving antifungal therapy and management of underlying conditions.

Main Results:

• BFS is suspected with positive urinary glucose and ethanol, negative ethanol metabolites, and yeast in urinalysis.
• GFS diagnosis requires demonstrating endogenous ethanol production via carbohydrate challenge tests.
• Both BFS and GFS can lead to failed abstinence monitoring, with GFS patients potentially showing positive blood alcohol tests.

Conclusions:

• Under-recognition of BFS and GFS can cause patient harm and adverse legal outcomes, such as DUI charges.
• Effective treatment involves eradicating the fermenting microorganisms and addressing the root cause (diabetes for BFS, gut dysbiosis for GFS).
• Distinguishing between BFS and GFS is critical for accurate diagnosis, treatment, and preventing alcohol-related health issues.